Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta‐analysis

Published:2019-04-17 Issue: Volume: Page:
ISSN:1045-3873
Container-title:Journal of Cardiovascular Electrophysiology
language:en
Short-container-title:J Cardiovasc Electrophysiol

Author:

Rattanawong Pattara¹²^ORCID,Kewcharoen Jakrin²,Mekraksakit Poemlarp³,Mekritthikrai Raktham¹,Prasitlumkum Narut¹,Vutthikraivit Wasawat⁴,Putthapiban Prapaipan⁵,Dworkin Jonathan⁶

Affiliation:

1. Department of Internal MedicineUniversity of Hawaii Internal Medicine Residency ProgramHonolulu Hawaii

2. Department of Internal Medicine, Faculty of Medicine, Ramathibodi HospitalMahidol UniversityBangkok Thailand

3. Department of MedicinePhramongkutklao College of MedicineBangkok Thailand

4. Department of MedicineTexas Tech University Health Sciences CenterLubbock Texas

5. Department of MedicineEinstein Medical CenterPhiladelphia Pennsylvania

6. Department of Internal MedicineUniversity of HawaiiHonolulu Hawaii

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jce.13932

Reference49 articles.

1. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003;Voigt A;J Am Coll Cardiol,2006

2. 16‐Year trends in the infection burden for pacemakers and implantable cardioverter‐defibrillators in the United States: 1993 to 2008;Greenspon AJ;J Am Coll Cardiol,2011

3. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights;Voigt A;Pacing and clinical electrophysiology: PACE,2010

4. Latest NICE guidelines on CRT and ICD devices in heart failure may significantly increase implant rates;Thabo Mahendiran OEG;Br J Cardiol,2015

5. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter‐defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance;Russo AM;J Am Coll Cardiol,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure — An unexplored risk factor for infective endocarditis after pacemaker implantation;Journal of Cardiology;2024-09

2. Incidence and Outcomes of Cardiovascular Implantable Electronic Device Infections in Patients with End-Stage Kidney Disease;Heart Rhythm;2024-09

3. Impact of psoriasis on the risk of device‐related infective endocarditis in patients with permanent pacemakers: a propensity‐matched analysis;International Journal of Dermatology;2024-06-06

4. Cardiac Resynchronization Therapy Devices Implantation Technique;From Supraventricular Tachycardias to Cardiac Resynchronization Therapy [Working Title];2024-04-12

5. Un germen inesperado: presentación atípica de infección de bolsillo de dispositivo de estimulación cardiaca por Vagococcus fluvialis;Cardiovascular and Metabolic Science;2024